Programme: 09:30 ­– 09:45 Registration, refreshments and expenses 09:45 – 10:00 Welcome, introductions, UKCAB updates 10:00 – 11:15 TB and HIV – Dr Santino Capocci, Royal Free Hospital 11:15 – 11.30 Break 11:30 – 12.15 TB-HIV: Strengthening Community Response – Gitau Mburu, Int. HIV/AIDS Alliance 12:15 – 12.45 Company pre-meeting on TMC207 – Polly Clayden, [...]

Programme 09:30–10:00 Registration, refreshments and expenses 10:00–10:15 Welcome, introductions, UKCAB updates 10:15–10:30 Introduction to London HIV drug prescribing – Simon Collins 10.30–11.00 NAT Response to London HIV drug prescribing – Yusef Azad, NAT 11:15–11.30 Break 11:30–12:00 Moderated discussion on London HIV drug prescribing 12.00–12:30 BHIVA standards of care document: community input – Roger Pebody, NAM [...]

UK-CAB 37 Meeting report Treatment as prevention iPrEX Trial design; statistical aspect of the results relating  to the adherence data Science behind PrEP/Pharmacology Training; complexity of how drugs  are absorbed and measured in different body compartments, and particularly for PrEP Company meeting: Gilead PIVOT trial: possible analyses of collected data

Friday 15 April 2011 At the MRC Clinical Trials Unit, 222 Euston Road, London, NW1 Venue Programme Background reading Hotel Details Expenses Programme 09:30-09:50 Registration, refreshments and expenses 09:50-10:00 Welcome, introductions, UKCAB updates 10:00-11:00 HIV and brain function – Dr Tristan Barber 11:10-11.30 Pre-Meeting for Abbott – Ben Cromarty 11:30-11:45 Break 11:45-12:45 HIV, antiretroviral therapy [...]

Friday 4 February 2011 Programme Background reading Presentations from this meeting Programme 09:30–10:00 Registration, refreshments and expenses 10:00–10:05 Welcome and UKCAB updates 10:05–10.30 Pre-Meeting for Gilead 10:30–11:30 iPrEX Trial design; statistical aspect of the results relating to the adherence data – Dr Colette Smith 11:30–11:40 Break 11:40–12:40 Science behind PrEP/Pharmacology Training; complexity of how drugs [...]